Oral solution containing sodium iodide (Na¹³¹I), sodium thiosulphate and sodium carbonate-bicarbonate buffer

 

MON.IYOT-131 74 – 18500 MBq oral solution contains fission product radioactive iodine (¹³¹I) as an active substance which has 8.02 days half life and used for diagnosis and treatment of thyroid diseases.

 

2 mCi(74 MBq), 5 mCi (185 MBq), 10 mCi (370 MBq), 15 mCi (555 MBq), 20 mCi (740 MBq), 25 mCi (925 MBq), 30 mCi (1110 MBq), 50 mCi (1850 MBq), 60 mci (2220 MBq), 75 mCi (2775 MBq), 80 mCi (2960 MBq), 100 mCi (3700 MBq), 125 mCi (4625 MBq), 150 mCi (5550 MBq), 175 mCi (6475 MBq), 200 mCi (7400 MBq), 250 mCi (9250 MBq), 300 mCi (11100 MBq), 400 mCi (14800 MBq), 500 mCi (18500 MBq)

 

Wednesday and Saturday

 

Next Wednesday (8 a.m.) after production or other days depending on request

 

30 days from the production

 

At room temperature below 25 ⁰C, in lead shield

 

Type I glass vial with bromobutyl rubber stoper in lead shield in a box